RANEXA

Prolonged-release tablet, 375mg
RxActive license

Active substance (INN)

ranolazine

Pharmaceutical form

Pharmaceutical formProlonged-release tablet
Strength375mg
PackagingUkupno 60 tableta sa produženim oslobađanjem u blisteru (3x20) u kartonskoj kutiji
ManufacturerMenarini - Von Heyden GmbH, Germany
Therapeutic groupCardiovascular system (C01EB18)
Marketing authorization holder"BERLIN-CHEMIE/MENARINI MONTENEGRO" D.O.O.- PODGORICA
Authorization dateMay 11, 2023

Analogs in Montenegro

2

Other medicines with the same active substance

RANEXARx
Prolonged-release tablet, 500mgMenarini - Von Heyden GmbH
RANEXARx
Prolonged-release tablet, 750mgMenarini - Von Heyden GmbH
Source: CInMED register